✦ LIBER ✦

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

✍ Scribed by Gadelha, Mônica R; Bronstein, Marcello D; Brue, Thierry; Coculescu, Mihail; Fleseriu, Maria; Guitelman, Mirtha; Pronin, Vyacheslav; Raverot, Gérald; Shimon, Ilan; Lievre, Kayo Kodama; Fleck, Juergen; Aout, Mounir; Pedroncelli, Alberto M; Colao, Annamaria

Book ID: 126476141
Publisher: Elsevier
Year: 2014
Tongue: English
Weight: 364 KB
Volume: 2
Category: Article
ISSN: 2213-8587
DOI: 10.1016/S2213-8587(14)70169-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OR7-7: Pasireotide LAR provides superior

OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)

✍ Fleseriu, M.; Gadelha, M.; Bronstein, M.D.; Brue, T.; Coculescu, M.; Guitelman, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Axillary dissection versus no axillary d

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

✍ Galimberti, Viviana; Cole, Bernard F; Zurrida, Stefano; Viale, Giuseppe; Luini, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 317 KB

Efficacy and safety of canagliflozin ver

Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

✍ Cefalu, William T; Leiter, Lawrence A; Yoon, Kun-Ho; Arias, Pablo; Niskanen, Leo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 489 KB

Trastuzumab in combination with chemothe

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

✍ Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Aki 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 332 KB

Pixantrone dimaleate versus other chemot

Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial

✍ Ruth Pettengell; Bertrand Coiffier; Geetha Narayanan; Fernando Hurtado de Mendoz 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 322 KB

Simeprevir with pegylated interferon alf

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

✍ Manns, Michael; Marcellin, Patrick; Poordad, Fred; de Araujo, Evaldo Stanislau A 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 287 KB